These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 20516273)
21. Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial. Dorman SE; Savic RM; Goldberg S; Stout JE; Schluger N; Muzanyi G; Johnson JL; Nahid P; Hecker EJ; Heilig CM; Bozeman L; Feng PJ; Moro RN; MacKenzie W; Dooley KE; Nuermberger EL; Vernon A; Weiner M; Am J Respir Crit Care Med; 2015 Feb; 191(3):333-43. PubMed ID: 25489785 [TBL] [Abstract][Full Text] [Related]
22. Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing. Pham MM; Podany AT; Mwelase N; Supparatpinyo K; Mohapi L; Gupta A; Samaneka W; Omoz-Oarhe A; Langat D; Benson CA; Chaisson RE; Swindells S; Fletcher CV Antimicrob Agents Chemother; 2022 Sep; 66(9):e0238521. PubMed ID: 35943252 [TBL] [Abstract][Full Text] [Related]
23. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers. Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240 [TBL] [Abstract][Full Text] [Related]
24. Physiologically Based Pharmacokinetic Model of Rifapentine and 25-Desacetyl Rifapentine Disposition in Humans. Zurlinden TJ; Eppers GJ; Reisfeld B Antimicrob Agents Chemother; 2016 Aug; 60(8):4860-8. PubMed ID: 27270284 [TBL] [Abstract][Full Text] [Related]
25. Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers. Dooley KE; Savic RM; Park JG; Cramer Y; Hafner R; Hogg E; Janik J; Marzinke MA; Patterson K; Benson CA; Hovind L; Dorman SE; Haas DW; Antimicrob Agents Chemother; 2015; 59(6):3399-405. PubMed ID: 25824215 [TBL] [Abstract][Full Text] [Related]
26. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics. Bramer SL; Forbes WP Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883 [TBL] [Abstract][Full Text] [Related]
27. Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine. Brooks KM; George JM; Pau AK; Rupert A; Mehaffy C; De P; Dobos KM; Kellogg A; McLaughlin M; McManus M; Alfaro RM; Hadigan C; Kovacs JA; Kumar P Clin Infect Dis; 2018 Jul; 67(2):193-201. PubMed ID: 29415190 [TBL] [Abstract][Full Text] [Related]
28. Impact of food and different meal types on the pharmacokinetics of rilpivirine. Crauwels HM; van Heeswijk RP; Buelens A; Stevens M; Boven K; Hoetelmans RM J Clin Pharmacol; 2013 Aug; 53(8):834-40. PubMed ID: 23720136 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of rifapentine in patients with varying degrees of hepatic dysfunction. Keung AC; Eller MG; Weir SJ J Clin Pharmacol; 1998 Jun; 38(6):517-24. PubMed ID: 9650541 [TBL] [Abstract][Full Text] [Related]
30. Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis? Alfarisi O; Alghamdi WA; Al-Shaer MH; Dooley KE; Peloquin CA Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1027-1036. PubMed ID: 28803492 [TBL] [Abstract][Full Text] [Related]
31. Rifapentine: its role in the treatment of tuberculosis. Temple ME; Nahata MC Ann Pharmacother; 1999 Nov; 33(11):1203-10. PubMed ID: 10573321 [TBL] [Abstract][Full Text] [Related]
32. The effect of different meal compositions on the oral bioavailability of treprostinil diolamine in healthy volunteers. Lim A; Wang-Smith L; Kates J; Laurent A; Kumar P; Laliberte K J Clin Pharm Ther; 2013 Dec; 38(6):450-5. PubMed ID: 23927483 [TBL] [Abstract][Full Text] [Related]
33. Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder. Chan JG; Tyne AS; Pang A; McLachlan AJ; Perera V; Chan JC; Britton WJ; Chan HK; Duke CC; Young PM; Traini D Int J Antimicrob Agents; 2015 Mar; 45(3):319-23. PubMed ID: 25554469 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the pharmacokinetic interaction between repeated doses of rifapentine or rifampin and a single dose of bedaquiline in healthy adult subjects. Winter H; Egizi E; Murray S; Erondu N; Ginsberg A; Rouse DJ; Severynse-Stevens D; Pauli E Antimicrob Agents Chemother; 2015 Feb; 59(2):1219-24. PubMed ID: 25512422 [TBL] [Abstract][Full Text] [Related]
35. The pharmacokinetics of cinacalcet are unaffected following consumption of high- and low-fat meals. Padhi D; Salfi M; Harris RZ Am J Ther; 2007; 14(3):235-40. PubMed ID: 17515696 [TBL] [Abstract][Full Text] [Related]
36. Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis. Rosenthal IM; Williams K; Tyagi S; Vernon AA; Peloquin CA; Bishai WR; Grosset JH; Nuermberger EL Am J Respir Crit Care Med; 2005 Dec; 172(11):1457-62. PubMed ID: 16141439 [TBL] [Abstract][Full Text] [Related]
37. A Phase 1, Randomized, Single-Dose Crossover Pharmacokinetic Study to Investigate the Effect of Food Intake on Absorption of Orteronel (TAK-700) in Healthy Male Subjects. Suri A; Pham T; MacLean DB Clin Pharmacol Drug Dev; 2016 May; 5(3):188-95. PubMed ID: 27163497 [TBL] [Abstract][Full Text] [Related]
38. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys. Emary WB; Toren PC; Mathews B; Huh K Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285 [TBL] [Abstract][Full Text] [Related]
39. The effect of food on the absorption of oral ziprasidone. Miceli JJ; Glue P; Alderman J; Wilner K Psychopharmacol Bull; 2007; 40(3):58-68. PubMed ID: 18007569 [TBL] [Abstract][Full Text] [Related]
40. Effect of Food on the Bioavailability of Omadacycline in Healthy Participants. Tzanis E; Manley A; Villano S; Tanaka SK; Bai S; Loh E J Clin Pharmacol; 2017 Mar; 57(3):321-327. PubMed ID: 27539539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]